# Aleks Radovic-Moreno

> Aleks Radovic-Moreno is a Series A investor at Longwood Fund backing Medical and Life Science. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Longwood Fund](https://shizune.co/investors/profile/longwood-founders-fund)
- Location: Boston, United States
- Total investments: 1
- Last investment: May 2024
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/aleksrm/
- X (Twitter): https://twitter.com/aradovicm?lang=en
- Website: https://x.com/aradovicm?lang=en

Aleks Radovic-Moreno is a Series A investor at Longwood Fund in Boston focused on Medical and Life Science. Radovic-Moreno is a Co-Founder of Vor and Vice President at PureTech. He was previously a Research Scientist at the biotech startup AuraSense Therapeutics, where he was a lead inventor of the company's core immunotherapy platform. Dr. Radovic-Moreno completed his graduate work as a NSF Fellow in Robert Langer's lab at MIT, where hedeveloped novel strategies for managing bacterial infections, including a novel vaccine candidate for chlamydia, a disease for which no vaccine currently exists. Dr. Radovic-Moreno was awarded the Alumni Achievement Award by the Pennsylvania State University for extraordinary professional accomplishment by graduates under the age of 35. Dr. Radovic-Moreno received his B.S. in Chemical Engineering from the Pennsylvania State University and PhD in Chemical and Biomedical Engineering from MIT and the Harvard-MIT Division of Health Sciences & Technology.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Life Science | 1 | 100% |
| Therapeutics | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Progentos Therapeutics | Progentos Therapeutics develops an approach to treat multiple sclerosis that stimulates the body's natural repair mechanisms. | $65M | Series A | May 14, 2024 |  |

1 of 1 investments shown.

## Co-investors
- [Forbion Capital Partners](https://shizune.co/investors/profile/forbion-capital-partners) — VC Fund, 2 deals together
- [Alta Partners](https://shizune.co/investors/profile/alta-partners) — VC Fund, 1 deal together
- [Mission BioCapital](https://shizune.co/investors/profile/bioinnovation-capital) — VC Fund, 1 deal together
- [Dolby Family Ventures](https://shizune.co/investors/profile/dolby-family-ventures) — VC Fund, 1 deal together

## About Longwood Fund

VC Fund · Boston, United States

Longwood creates and invests in science-based companies that develop novel solutions for important medical problems

5 contacts available at Longwood Fund.

| Name | Title | Profile |
| --- | --- | --- |
| Aleks Radovic-Moreno | Partner | https://shizune.co/investors/profile/aleks-radovic-moreno |
| John McCabe | Operating Partner | https://shizune.co/investors/profile/john-mccabe-d84c |
| Christoph Westphal | Manager | https://shizune.co/investors/profile/christoph-westphal |
| David Donabedian | Executive Partner | https://shizune.co/investors/profile/david-donabedian |
| David Donabedian, PhD | Venture Partner | https://shizune.co/investors/profile/david-h-donabedian |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Aleks Radovic-Moreno invest in?

Aleks Radovic-Moreno invests primarily in Medical, Life Science and Therapeutics startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Aleks Radovic-Moreno last invest?

The most recent investment recorded for Aleks Radovic-Moreno closed in May 2024. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co